The Recall Desk
SevereFDA (Drugs)·D-0625-2017·Announced 2017-04-12

Shire Recalls Kalbitor Due to Presence of Glass Particulate Matter

Shire is recalling specific lots of Kalbitor (ecallantide) injection because glass particles were found in the product.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, and the presence of glass particulate matter in a subcutaneous injectable drug poses a significant risk of injury, meeting the criteria for a Severe rating.

Plain-English summary

Shire is voluntarily recalling 3,536 cartons of Kalbitor (ecallantide), 10mg/mL, packaged in 3 vials per carton. The recall is due to the presence of particulate matter, specifically glass, in the product. The affected lot number is A1500009, with an expiration date of January 31, 2019.

The recalled product was distributed nationwide and in Kuwait. Kalbitor is a prescription medication administered via subcutaneous injection. The presence of glass particles in an injectable medication poses a risk of injury to patients.

Patients and healthcare providers should stop using the affected lot of Kalbitor and contact their healthcare provider or Shire for further instructions. Consumers should check their medication packaging for the lot number A1500009 and expiration date of January 31, 2019, to determine if they have the affected product.

The recalled product

Product
KALBITOR (ECALLANTIDE)
Brand
KALBITOR
Manufacturer
Shire

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot #: A1500009
  • Exp. Jan 31
  • 2019

Distribution

Distributed nationwide across the United States.

Same manufacturer · Shire

See all →